Tuesday, November 3, 2026

WHEN WILL US LEARN? Washington Shifts To ‘Coexistence’ While China Threatens Taiwan With War

The U.S. is shifting from viewing China as an adversary to a manageable partner, aiming for economic coexistence despite tensions.

New Communism Axis: Why Vietnam is Now the ‘Fourth Partner’ in Kim Jong-un’s Strategy

North Korea's 80th anniversary event hints at a diplomatic shift, positioning Vietnam as a key player alongside China and Russia.

PREPARING THE IRAN-PYONGYANG AXIS: How Kim’s Lethal Joint Tactical Drills are Training an Unstoppable Force for Global Conquest

Kim Jong Un observed a tactical drill showcasing North Korea's military capabilities, including new tanks and drone operations.

Health

[Interview] Beyond Drug Discovery: AI-Driven Manufacturing Innovation Aims to Cut Costs by 30% and Defect Rates by 5%

Young-joon Park, president of the Pharmaceutical Manufacturing Innovation Society, says AI-powered digital continuous manufacturing could reduce drug production costs by 30% and defect rates by 5%, but clearer regulations and sustained government support are needed to accelerate adoption in South Korea.

SK Biopharmaceutical’s Epilepsy Drug Xcopri Now Available in South Korea, Cutting Monthly Medication Costs by Up to $200

Xcopri, an epilepsy medication developed by SK Biopharmaceutical, has begun domestic distribution and is now covered by South Korea’s national health insurance, potentially saving patients who previously obtained it in the United States up to $200 a month in medication costs.

GC Biopharma Signs $39.5 Million Flu Vaccine Supply Deal With Colombia’s VaxThera

GC Biopharma has signed an approximately $39.5 million agreement with Colombian vaccine company VaxThera to supply influenza vaccine bulk material and provide technical support for local production of its GC Flu vaccine.

Inventage Lab Completes Phase 1 Trial of Addiction Treatment, Plans U.S. Phase 2 Study

Inventage Lab has obtained the final clinical study report for its month-long extended-release addiction treatment IVL3004, with plans to pursue further global trials, including a U.S. Phase 2 study, and explore licensing opportunities.

Samsung Biologics Secures 97.98% Stake in Polypeptide Tender Offer, Clearing Path for Acquisition

Samsung Biologics has secured 97.98% of Polypeptide Group’s shares through its tender offer, exceeding the 90% threshold required for a squeeze-out of remaining minority shareholders and paving the way for full ownership.
Latest

ABL209 Receives FDA Approval: What This Dual Antibody ADC Means for Cancer Treatment

ABL Bio receives FDA approval for ABL209, a bispecific antibody-drug conjugate, advancing ADC development for solid tumors.

Wontech’s Game-Changing Medical Solutions: 4 New Contracts Signed at IMCAS 2026!

Wontech secures contracts in four regions at IMCAS 2026, showcasing products and enhancing global presence in aesthetic medical devices.

K-Beauty Devices Go Global: Wontech Expands to 60+ Countries With a Canada Green Light for V-Laser

Wontech, a medical solutions firm, is rapidly expanding globally, recently securing V-Laser certification in Canada for North American markets.

SK Chemicals’ Joins Tablet Surpasses 700 Billion KRW in Sales… What’s Behind the Osteoarthritis Drug’s Success?

SK Chemicals' Joins Tablets, a natural osteoarthritis treatment, surpasses 700 billion KRW in sales, marking a significant milestone in Korea.

Why Simparica Trio is the Top Choice for Pet Owners: 100% Heartworm Prevention Explained

Zoetis launches Simparica Trio in South Korea, a monthly parasite chew for pets, combining multiple treatments for effective protection.

How JNPMEDI Plans to Achieve 250% Revenue Growth in 2026: A Guide for Pharma Innovators

JNPMEDI aims to enhance its global role in drug and medical device development, achieving significant growth and expanding partnerships.

Celltrion’s Strategic Move: How Local Production in the U.S. Can Mitigate Tariff Risks

Celltrion outlines its Branchburg facility's operations and plans to mitigate tariff risks by establishing local production and a supply system.

Why Samsung Medical Center is Now Korea’s Top Hospital: A Deep Dive into the 2026 Rankings

Samsung Medical Center ranks as South Korea's top hospital and 26th globally in Newsweek's World's Best Hospitals 2026 list.

Samsung Biologics: How a 56 Billion USD CDMO Leader is Shaping the Future of Biopharmaceuticals

Samsung Biologics is evolving as a leading CDMO, targeting a production capacity of 1.32M liters by 2030 after its spin-off from Bioepis.

K-Biohealth Surge: How AI and Precision Medicine are Transforming Global Markets in 2026

South Korean biohealth firms are expanding globally, showcasing AI solutions and forming partnerships at major healthcare events.

What Makes DOOTH the Game-Changer in Absorbable Sutures? Discover Its Unique Advantages!

CGBio is expanding its aesthetic business by exporting the absorbable suture DOOTH to Japan, aiming for global recognition and regulatory approvals.

Korea’s Olive Young Gets a New Sleep Aid: Daewon Launches Honey Sleep Shot Backed by a Study

Daewon Health launches Honey Sleep Shot, a plant-based sleep aid, in 900 Olive Young stores, targeting sleep issues for modern consumers.

Novo Nordisk Slashes GLP-1 Drug Prices by Up to 50%: What This Means for Obesity Treatments in 2027

Novo Nordisk will cut prices of GLP-1 treatments in the U.S. by up to 50% from January 2027, amid rising competition and market pressures.

Hemlibra Breakthrough: 91% of Hemophilia Patients in Japan Experience No Adverse Reactions!

JW Pharmaceutical's Hemlibra shows 91% safety in Japanese hemophilia patients, with no adverse reactions in long-term study.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.